News Focus
News Focus
icon url

kevindenver

10/17/25 9:40 AM

#503416 RE: Hoskuld #503412

Failure is yet to be determined as if Missling is successful with a Full or reasonable CMA with the current trial data, I'm positive history will be kind.
Bullish
Bullish
icon url

tredenwater2

10/17/25 9:53 AM

#503420 RE: Hoskuld #503412

I am unhappy that this company has such incredibly good therapeutic assets but they squander their opportunities to capitalize on them. SMH.



If they ran another ph3 our stock would be in the $3-$5 range from the crooks squeezing Dr. Missling at a time when he needs money. Ghe 130 million would not be enough and would being us dangerously low.

If Dr. Missling gets the ball across the goal line with EU approval he/we win!

Why not wait another 30 days before judging.
icon url

tradersbend

10/31/25 8:57 PM

#505399 RE: Hoskuld #503412

In all fairness, during one of Obama’s terms the FDA (Scott Gottlieb) was pushing smaller trials.
I have no idea of this was the case.